Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile -: Associated disease caused by the hypervirulent NAP1/027 strain

被引:241
作者
Valiquette, Louis
Cossette, Benoit
Garant, Marie-Pierre
Diab, Hassan
Pepin, Jacques
机构
[1] Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada
[2] CHU Sherbrooke, Dept Pharm, Sherbrooke, PQ J1H 5N4, Canada
[3] CHU Sherbrooke, Clin Res Ctr, Sherbrooke, PQ J1H 5N4, Canada
关键词
D O I
10.1086/519258
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A series of measures were implemented, in a secondary/tertiary-care hospital in Quebec, to control an epidemic of nosocomial Clostridium difficile-associated disease (n-CDAD) caused by a virulent strain; these measures included the development of a nonrestrictive antimicrobial stewardship program. Interrupted time-series analysis was used to evaluate the impact of these measures on n-CDAD incidence. From 2003-2004 to 2005-2006, total and targeted antibiotic consumption, respectively, decreased by 23% and 54%, and the incidence of n-CDAD decreased by 60%. No change in n-CDAD incidence was noted after strengthening of infection control procedures (P = .63), but implementation of the antimicrobial stewardship program was followed by a marked reduction in incidence (P = .007). This suggests that nonrestrictive measures to optimize antibiotic usage can yield exceptional results when physicians are motivated and that such measures should be a mandatory component of n-CDAD control. The inefficacy of infection control measures targeting transmission through hospital personnel might be a result of their implementation late in the epidemic, when the environment was heavily contaminated with spores.
引用
收藏
页码:S112 / S121
页数:10
相关论文
共 37 条
[31]   Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections [J].
Solomkin, JS ;
Mazuski, JE ;
Baron, EJ ;
Sawyer, RG ;
Nathens, AB ;
DiPiro, JT ;
Buchman, T ;
Dellinger, EP ;
Jernigan, J ;
Gorbach, S ;
Chow, AW ;
Bartlett, J .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (08) :997-1005
[32]  
Thomas Claudia, 2003, Commun Dis Intell Q Rep, V27 Suppl, pS28
[33]   Clostridium difficile infection in hospitals:: a brewing storm [J].
Valiquette, L ;
Low, DE ;
Pépin, J ;
McGeer, A .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (01) :27-29
[34]   Segmented regression analysis of interrupted time series studies in medication use research [J].
Wagner, AK ;
Soumerai, SB ;
Zhang, F ;
Ross-Degnan, D .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2002, 27 (04) :299-309
[35]   Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe [J].
Warny, M ;
Pepin, J ;
Fang, A ;
Killgore, G ;
Thompson, A ;
Brazier, J ;
Frost, E ;
McDonald, LC .
LANCET, 2005, 366 (9491) :1079-1084
[36]   Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea [J].
Wilcox, MH ;
Freeman, J ;
Fawley, W ;
MacKinlay, S ;
Brown, A ;
Donaldson, K ;
Corrado, O .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (01) :168-172
[37]  
World Health Organization, 2006, ATC DDD IND 2006